Wed, September 18, 2024
Tue, September 17, 2024
Mon, September 16, 2024
Fri, September 13, 2024
Thu, September 12, 2024

Aydin Huseynov Upgraded (ACRV) to Strong Buy and Held Target at $16 on, Sep 16th, 2024


//stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-16-on-sep-16th-2024.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Aydin Huseynov of Ladenburg Thalmann, Upgraded "Acrivon Therapeutics, Inc." (ACRV) to Strong Buy and Held Target at $16 on, Sep 16th, 2024.

Aydin, nor any peers, have made any analyst calls on ACRV in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Publication Contributing Sources